Navigation Links
Cryoablation continues to show good results for kidney cancer patients
Date:11/25/2007

ROCHESTER, Minn. -- A review of 62 Mayo Clinic patients who underwent cryoablation to treat cancerous kidney tumors shows that the patients are cancer free for up to two and a half years after having had the procedure.

Also called cryotherapy or cryosurgery, cryoablation is a procedure in which extreme cold is applied to the tumor using a cryoprobe, a hollow needle-like device filled with argon gas. The gas rapidly freezes the targeted tumor.

As this study and others continue to show, cryoablation appears to be an effective treatment for cancerous kidney tumors. But researchers caution that at this time, it be used only for patients who are not candidates for surgery, because follow-up studies are needed before the procedure can be widely applied, states Thomas Atwell, M.D., a Mayo Clinic radiologist and the study's primary investigator.

Dr. Atwell will present these findings on Sunday, Nov. 25 at the annual meeting of the Radiological Society of North America in Chicago.

This procedure appears to be a good option for some patients, he says. The general criteria for cryoablation includes the size and appearance of the tumor and the number of lesions in the kidney.

In this study, 89 of 91 tumors were effectively treated in a single treatment session. Patients had tumors that ranged in size from 1.5 centimeters (cm) to 7.3 cm. The average size was 3.4 cm. Follow-up evaluations ranging from three months to two and a half years were available for 62 patients -- all whom remain cancer free at last report.

The standard treatment for kidney tumors is surgery, which is highly effective. For patients who undergo surgery, the hospital stay and recovery period are longer as compared to patients treated with cryoablation. Patients who undergo cryoablation will have small inch incision where the cryoprobe is inserted. The mark is covered with a bandage and recovery usually amounts to one day in hospital, as compared to several days for patients who undergo surgery.


'/>"/>

Contact: Amy Reyes
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. New Study Data Published in British Journal of Urology Demonstrates Cryoablation Effective for Kidney Cancer
2. Medicare Increases 2008 Hospital Reimbursement Rates for Cryoablation Treatments of Prostate Cancer
3. Medicare Sets Physician Payment Rate for Percutaneous Kidney Cryoablation
4. Battle Continues Over Vietnam PTSD Numbers
5. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
6. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
7. Securians Minnesota Life Continues to Climb Group Life Rankings
8. USA TODAY Continues Spirit of the USA Charity Program as Part of Newspapers 25th Anniversary Celebration
9. United States continues to have highest level of health spending
10. LehmanMillet Continues Expansion with Strategic Hires
11. American Cancer Society report finds breast cancer death rate continues to drop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Pekin, IL (PRWEB) , ... February 24, 2017 , ... ... in the 7th annual “Imagine Me Beyond What You See” body image mannequin art ... Professional’s Choice will be showcased and the winner revealed at the 31st annual iaedp ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations ... International Elite division on February 12th. Ms. Esparza qualified into this prestigious ... qualifier competition held in Las Vegas, Nevada. Frida is one of approximately 25 ...
(Date:2/23/2017)... ... , ... The 89th Academy Awards will be celebrated this weekend, which means ... Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek “salute” to the ... Center for American Progress (CAP), for its report, Lessons From State Performance on NAEP: ...
(Date:2/23/2017)... ... , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will be ... Hot,” which will begin airing on February 24, 2017. The show chronicles the weight ... reality television series, “Here Comes Honey Boo Boo.” The earlier series from TLC lasted ...
(Date:2/23/2017)... ... February 23, 2017 , ... On ... a diverse symposium on “Doping in Sport: How the Culture Might Change,” ... & Hampton LLP. The symposium will be held at Pepperdine University in Malibu, ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017 Regulus Therapeutics Inc ... and development of innovative medicines targeting microRNAs, today announced ... financial results on Thursday, March 2, 2017 after the ... call and webcast on March 2, 2017 at 5:00 ... year 2016 financial results and provide a general business ...
(Date:2/23/2017)... ... Markets has announced the addition of the "Global Antifungal Drugs Market ... offering. The Global Antifungal Drugs Market is poised to ... reach approximately $12.8 billion by 2025. This industry ... on global as well as regional levels presented in the research scope. ...
(Date:2/23/2017)... MARIETTA, Ga., Feb. 23, 2017  MiMedx Group, Inc. ... amniotic tissue and patent-protected processes to develop and market ... Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of ... quarter and full year ended December 31, 2016. ... Revenue is a 31% increase over full year ...
Breaking Medicine Technology: